Literature DB >> 7521927

Partial remission of parotid gland carcinoma after goserelin.

R W van der Hulst, J H van Krieken, T H van der Kwast, J J Gerritsen, R J Baatenburg de Jong, A A Lycklama à Nijeholt, A E Meinders.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7521927     DOI： 10.1016/s0140-6736(94)92372-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Salivary gland cancers: biology and molecular targets for therapy.

Authors:  Diana Bell; Ehab Y Hanna
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

Review 2.  Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.

Authors:  Aaron M Udager; Simion I Chiosea
Journal:  Head Neck Pathol       Date:  2017-03-20

3.  Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors.

Authors:  Nhu Thuy Can; Mark W Lingen; Heather Mashek; James McElherne; Renee Briese; Carrie Fitzpatrick; Annemieke van Zante; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2017-07-05

4.  Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.

Authors:  Tatsuo Masubuchi; Yuichiro Tada; Shin-ichiro Maruya; Yoshiyuki Osamura; Shin-etsu Kamata; Kouki Miura; Chihiro Fushimi; Hideaki Takahashi; Daisuke Kawakita; Seiji Kishimoto; Toshitaka Nagao
Journal:  Int J Clin Oncol       Date:  2014-02-20       Impact factor: 3.402

Review 5.  Systemic therapy in the management of metastatic or advanced salivary gland cancers.

Authors:  Aymen Lagha; Nesrine Chraiet; Mouna Ayadi; Sarra Krimi; Bassem Allani; Hela Rifi; Henda Raies; Amel Mezlini
Journal:  Head Neck Oncol       Date:  2012-05-04

Review 6.  Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.

Authors:  Jan Bogaerts; Matthew R Sydes; Nicola Keat; Andrea McConnell; Al Benson; Alan Ho; Arnaud Roth; Catherine Fortpied; Cathy Eng; Clare Peckitt; Corneel Coens; Curtis Pettaway; Dirk Arnold; Emma Hall; Ernie Marshall; Francesco Sclafani; Helen Hatcher; Helena Earl; Isabelle Ray-Coquard; James Paul; Jean-Yves Blay; Jeremy Whelan; Kathy Panageas; Keith Wheatley; Kevin Harrington; Lisa Licitra; Lucinda Billingham; Martee Hensley; Martin McCabe; Poulam M Patel; Richard Carvajal; Richard Wilson; Rob Glynne-Jones; Rob McWilliams; Serge Leyvraz; Sheela Rao; Steve Nicholson; Virginia Filiaci; Anastassia Negrouk; Denis Lacombe; Elisabeth Dupont; Iris Pauporté; John J Welch; Kate Law; Ted Trimble; Matthew Seymour
Journal:  Eur J Cancer       Date:  2014-12-24       Impact factor: 9.162

Review 7.  Androgen Receptor Signaling in Salivary Gland Cancer.

Authors:  Martin G Dalin; Philip A Watson; Alan L Ho; Luc G T Morris
Journal:  Cancers (Basel)       Date:  2017-02-08       Impact factor: 6.639

8.  Case report: anti-hormonal therapy in the treatment of ductal carcinoma of the parotid gland.

Authors:  Saúl Campos-Gómez; Jose H Flores-Arredondo; Rita Dorantes-Heredia; Mónica Chapa-Ibargüengoitia; Roberto de la Peña-Lopez
Journal:  BMC Cancer       Date:  2014-09-23       Impact factor: 4.430

9.  Androgen Receptor Expression in Primary Nonsquamous Cell Rare-Variant Carcinomas of the Head and Neck.

Authors:  Siavash Rahimi; Katherine L Bradley; Iolia Akaev; Carla Marani; Chit Cheng Yeoh; Peter A Brennan
Journal:  OTO Open       Date:  2017-06-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.